(Q36385157)

13 August 2017

1 reference

title

Serum amyloid A: the "other" inflammatory protein (English)

1 reference

13 August 2017

0 references

Kevin D O'Brien

1

1 reference

PubMed ID

16455016

13 August 2017

Alan Chait

series ordinal

2

1 reference

13 August 2017

1 January 2006

1 reference

Current Atherosclerosis Reports

13 August 2017

1 reference

13 August 2017

8

1 reference

13 August 2017

1

1 reference

13 August 2017

62-68

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-006-0066-0

13 August 2017

0 references

cites work

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0066-0

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0066-0

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0066-0

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0066-0

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

12 December 2020

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

1 reference

12 December 2020

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

1 reference

12 December 2020

A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion

1 reference

12 December 2020

Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function

1 reference

12 December 2020

The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project

1 reference

12 December 2020

Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)

1 reference

12 December 2020

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

12 December 2020

Effect of C-reactive protein on chemokine expression in human aortic endothelial cells

1 reference

12 December 2020

Differentiation between obesity and insulin resistance in the association with C-reactive protein

1 reference

12 December 2020

C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

1 reference

12 December 2020

Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

1 reference

12 December 2020

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

12 December 2020

Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages

1 reference

12 December 2020

Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels

1 reference

12 December 2020

Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease

1 reference

12 December 2020

Statin therapy improves cardiovascular outcome of patients with peripheral artery disease

1 reference

12 December 2020

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

12 December 2020

Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins

1 reference

12 December 2020

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

12 December 2020

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

1 reference

12 December 2020

Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis

1 reference

12 December 2020

Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects

1 reference

12 December 2020

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

1 reference

12 December 2020

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase

1 reference

12 December 2020

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

1 reference

12 December 2020

Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line

1 reference

12 December 2020

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

1 reference

12 December 2020

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant

1 reference

12 December 2020

Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability

1 reference

12 December 2020

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

1 reference

12 December 2020

Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition

1 reference

12 December 2020

Elevated C-reactive protein levels in overweight and obese adults

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A.

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

Serum amyloid A, the major vertebrate acute-phase reactant

1 reference

12 December 2020

The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.

1 reference

12 December 2020

Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels

1 reference

12 December 2020

Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice

1 reference

12 December 2020

Introducing a new component of the metabolic syndrome: low cholesterol absorption.

1 reference

12 December 2020

Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts

1 reference

12 December 2020

Obesity and the metabolic syndrome in children and adolescents

1 reference

12 December 2020

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

1 reference

12 December 2020

Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects

1 reference

12 December 2020

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

1 reference

12 December 2020

Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function

1 reference

12 December 2020

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

1 reference

12 December 2020

Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1.

1 reference

12 December 2020

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Serum amyloid A and lipoprotein retention in murine models of atherosclerosis

1 reference

12 December 2020

Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening

1 reference

12 December 2020

CRP or not CRP? That is the question

1 reference

12 December 2020

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

1 reference

12 December 2020

10.1007/S11883-006-0066-0

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16455016